CyVek nails down $3M for diagnostics test system

Connecticut startup CyVek has nailed down $3 million in new funding toward the development of a test system designed to handle molecular diagnostics, immunodiagnostics and bioassays for both drug discovery and clinical care use, MassHighTech is reporting. CyVek, which launched in 2010, disclosed the funding in a federal filing. The company raised $4 million in a Series B round almost two years ago, according to the article, including $802,000 from Connecticut Innovations. Story

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.